Cargando…

Insulin Analogue Levemir and Development of Pancreatic Adenocarcinoma: A Case Report and Literature Review

There is an association between insulin analogues, glargine, lispro and aspart and the incidence of malignancies. A 76 year-old female patient with history of diabetes, hypertension and hyperlipidemia presented with flank pain after using insulin Levemir as part of her management. CT abdomen reveale...

Descripción completa

Detalles Bibliográficos
Autores principales: Arya, Aditya, Al-Waili, Noori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409627/
https://www.ncbi.nlm.nih.gov/pubmed/22870179
http://dx.doi.org/10.4021/jocmr936w
_version_ 1782239617051787264
author Arya, Aditya
Al-Waili, Noori
author_facet Arya, Aditya
Al-Waili, Noori
author_sort Arya, Aditya
collection PubMed
description There is an association between insulin analogues, glargine, lispro and aspart and the incidence of malignancies. A 76 year-old female patient with history of diabetes, hypertension and hyperlipidemia presented with flank pain after using insulin Levemir as part of her management. CT abdomen revealed pancreatic mass and endoscopic ultrasound- guided FNA aspiration biopsy showed pancreatic adenocarcinoma. It was not clear whether the insulin analogue initiated the tumor or helped the growth of pre-existing malignant foci. Then we concluded that case presented raises an indicator of possible association between using insulin analogue and initiation of malignancies, or stimulation of malignant foci.
format Online
Article
Text
id pubmed-3409627
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-34096272012-08-06 Insulin Analogue Levemir and Development of Pancreatic Adenocarcinoma: A Case Report and Literature Review Arya, Aditya Al-Waili, Noori J Clin Med Res Case Report There is an association between insulin analogues, glargine, lispro and aspart and the incidence of malignancies. A 76 year-old female patient with history of diabetes, hypertension and hyperlipidemia presented with flank pain after using insulin Levemir as part of her management. CT abdomen revealed pancreatic mass and endoscopic ultrasound- guided FNA aspiration biopsy showed pancreatic adenocarcinoma. It was not clear whether the insulin analogue initiated the tumor or helped the growth of pre-existing malignant foci. Then we concluded that case presented raises an indicator of possible association between using insulin analogue and initiation of malignancies, or stimulation of malignant foci. Elmer Press 2012-08 2012-07-20 /pmc/articles/PMC3409627/ /pubmed/22870179 http://dx.doi.org/10.4021/jocmr936w Text en Copyright 2012, Arya et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Arya, Aditya
Al-Waili, Noori
Insulin Analogue Levemir and Development of Pancreatic Adenocarcinoma: A Case Report and Literature Review
title Insulin Analogue Levemir and Development of Pancreatic Adenocarcinoma: A Case Report and Literature Review
title_full Insulin Analogue Levemir and Development of Pancreatic Adenocarcinoma: A Case Report and Literature Review
title_fullStr Insulin Analogue Levemir and Development of Pancreatic Adenocarcinoma: A Case Report and Literature Review
title_full_unstemmed Insulin Analogue Levemir and Development of Pancreatic Adenocarcinoma: A Case Report and Literature Review
title_short Insulin Analogue Levemir and Development of Pancreatic Adenocarcinoma: A Case Report and Literature Review
title_sort insulin analogue levemir and development of pancreatic adenocarcinoma: a case report and literature review
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409627/
https://www.ncbi.nlm.nih.gov/pubmed/22870179
http://dx.doi.org/10.4021/jocmr936w
work_keys_str_mv AT aryaaditya insulinanaloguelevemiranddevelopmentofpancreaticadenocarcinomaacasereportandliteraturereview
AT alwailinoori insulinanaloguelevemiranddevelopmentofpancreaticadenocarcinomaacasereportandliteraturereview